Arteris vs Ambiq Micro
Arteris and Ambiq Micro are similar in size: $70.6m and $72.5m of revenue in their latest fiscal years. Arteris grew faster (22.3% against -4.7%). Arteris kept more of each dollar of sales as profit: a net margin of -49.2% against -50.3%.
| Latest fiscal year | ArterisAIP, 2025 | Ambiq MicroAMBQ, 2025 |
|---|---|---|
| Revenue | $70.6m | $72.5m |
| Revenue growth | 22.3% | -4.7% |
| Net income | −$34.7m | −$36.5m |
| Operating margin | -47.0% | -54.5% |
| Net margin | -49.2% | -50.3% |
| Return on equity | — | — |
| Free cash flow | $5.3m | — |
| Cash | $33.9m | $140m |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 299 | 202 |
| Market value | $919m | $1.09bn |
| Price vs our value range | — | — |
| Moat score | 65 (Moderate) | — |
| Insider trades, 12 months | 0 buys, 221 sales | 0 buys, 79 sales |